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SEVERE ORGANOPHOSPHATE POISONING WITH DELAYED 
CHOLINERGIC CRISIS, INTERMEDIATE SYNDROME AND 
ORGANOPHOSPHATE INDUCED DELAYED 





Organophosphate compounds are the organic derivatives of Phosphorous containing acids and their 
effect on neuromuscular junction and Autonomic Synapses is clinically important. After exposure these 
agents cause acute and sub acute manifestations depending on the type and severity of the agents like 
Acute Cholinergic Manifestations, Intermediate Syndrome with Nicotinic features and Delayed Central 
Nervous System Complications. The patient reported here had severe Organophosphate Poisoning with 
various rare complications on a succession. This is the first report of Organophosphates Poisoning 
complicated by Intermediate Syndrome and Organophosphate Induced Delayed Polyneuropathy in 




Organophosphate compounds are the organic 
derivatives of Phosphorous containing acids and 
their effect on Neuromuscular Junction and 
Autonomic synapses is clinically important. In the 
Neuromuscular Junction Acetylcholine is released 
when a nerve impulse reaches terminal axonal end 
and it diffuses across the Synaptic Cleft and binds 
to Cholinergic Nicotinic receptors on the muscle 
fibers, causing them to contract.  The enzyme, 
Cholinesterase splits Acetylcholine into Acetic 
Acid and Choline, thus stopping its action (Figure 
1). The end products of the metabolism of 
Acetylcholine are taken up by nerve fibers and 
resynthesized into Acetylcholine. In 
Organophosphate poisoning the Cholinesterase are 
phosphorylated by the Phosphate end of 
Organophosphates; then the net result is 
accumulation of excessive Acetyl Chlorine with 
resultant effect on Muscarinic, Nicotinic and 
central nervous system (Figure 2). 
 
Following classical OP poisoning, three well 
defined clinical phases are seen: Initial Acute 
Cholinergic Crisis, the Intermediate Syndrome and 
Delayed Polyneuropathy (OPIDPN) .Here severe 
and prolonged cholinergic crisis with unusual 
complications, notably Intermediate Syndrome 
and OPIDPN are described in the same patient in 
different course of time. As far as the researcher’s 
knowledge is concerned, this is the first report of 
Intermediate Syndrome and OPIDPN in Ethiopia.’ 
 
                      
Figure 1: Acetylcholine, acetic acid, and choline    
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The patient was admitted to TASH for three weeks 
and discharged with improved status but three 
days after discharged, he had new clinical 
manifestations and these details are described. 
 
Immediate features and management 
 
A nineteen years old male patient from Addis 
Ababa who ingested unquantified amount of 
Malathion, which was kept at home, in an attempt 
to commit suicide on January 3, 2007. 
             
After he took the poison, he was found fallen 
and was given milk by the family members. 
Subsequently he lost consciouseness and was 
taken to a clinic on the same date where Atropine 
15mg IV every 15 minutes , Ceftraxone 1gm IV 
every 12 hours  and unquantified amount of 
Charcoal were adminstered. According to the 
referral and family informants, after three days he 
showed improvement with the recovery of 
consciousness and the medications were 
discontinued but he lost conscoiusiness again 
while he was still in the clinic and was referred to 
Tikur Anbessa specialized hospital(TASH) on 
January 6,2011. 
 
On physicale examination at Tikur 
Anbesa Specialized Hospital (TASH) emergency 
room his blood pressure was 90/60mmHG, pulse 
rate 76/min, respiratory rate 16/min  and 
temprature was  37.90c. He had Rhonchi all over 
the chest, pupils were pinpointed and Glasgow 
Coma Scale (GCS) was 3/15. He  also had  
paradoxic abdominal muscle movement. On 
investigations white blood cell count was 
11,500/dl,  Hematocrit 45.2%, Platele count 
129,000/dl,Erythrocyte Sedimentation rate 24/hr 
and Random Blood Sugar 108mg/dl. However, 
Serum Transaminases, Alkaline Phosphatases and 
liver and renal function tests and Serum 
Electrolytes were in normal range.Futhermore, 
chest X-ray was normal and ECG showed 
prolonged QTc interval(49ms).Oxygen saturation 
was 80% with 6L/min flow of oxygen through 
nasal prongs but subsequently with face mask it 
was consistently above 92%. 
 
He was admitted to the Medical Intensive 
Care Unit (MICU)  and with  an assessement of 
severe Organophosphate poisoning with Acute 
Cholinergic Crisis and Intermediate Syndrome and 
with Presumptive Diagnoses of  type II respiratory 
failure.He was atropinized  with Atropine 2mg stat 
and then 2 mg every 15 minutes, Charcoal 50 gm 
was given with in 4 hrs and 25 gm was continued 
every 6 hour. He had intensive monitoring of vital 
signs and organ functions. Ventilatory support was 
not started  since ventilators were  occupied by 
other patients but he was continued on  large dose 
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of Atropine(upto 90md/24hrs)  and oxygen adminstration of 6L/min by  face mask (Table 1). 
 
Table 1. Dose of atropine at TASH 
 
Time from date of malathion ingestion Range of atropine dosage in 24 hrs 
Day4-10 2 mg every 15-20 minutes 
Day 11-14 2 mg every 1-4 hours 
Day 15-19 1 mg every 1-6hrs 
Day 20-22 1 mg every 12-24 hours 
Day 23-25 0.4mg po QID 
Day 25(discharged) discontinued 
 
His GCS was 3/15 in the first 48hrs in the MICU 
after that he started to utter words but 
subsequently  the  level of consciuosness was 
waxing and waning.Therefore, he was continued 
with large dose of atropine with adminstration of 
2mg every 15minutes and on the third day of 
MICU  admission he was intubated and put on 
ventilatory support(Figure 3).In the meanwhile he 
developed Tonic Clonic Seizure and was started 
on Diazepam 5 mg IV stat and it was maintained 
with dose of 30mg in 1000cc of IV fluids every 12 
hours  for about 14 days and then discontiued after 
improvement of seizure. 
 
Cholinergic and central nervous system 
symptomes with pupillary constriction, respiratory 
hypersecreations and flactuating consciousness 
were pecuilar features with in the first three 
weeks; mental status was deteriorating when the 
dosage of Atropine was titrated down. By the end 
of three weeks mental status,pupilary signs 
,hypersecreation improved; he was extubated from 
ventilator;subsequently Atropine and Diazepam 
were spaced and discontinued. Finally,at the end 
of third week he was discharged after  psychiatric 
evaluation and caunselling was provided and was 





Post discharge manifestations 
 
Three days after discharge from the hospital he 
devloped numbness of both feet which was 
followed by weakness of both lower extremities 
which progresssed to involve upper extremity and  
urinary and feacal incontinence.On physical 
examination he was conscious and oriented. 
Power on both lower extremity was 0/5, while on 
upper extremity it was 3/5. Deep tendon reflexes 
were depressed at both extremities while tone was 
reduced on the lower extremity and all modalities 
of sensory examinations were normal. Further 
investigations after discharge showed normal 
Hematological and blood chemistry tests; was 
negative for HIV and had normal Myelography 
and spine x-rays.In addition,nerve conduction test 
showed no motor response from Tibial and 
Peroneal nerves and there was severe reduction in 
amplitude of right Median motor nerve. However 
the sural and plantar sensory nerves were 
normal.Thus,severe motor axonal neuropathy 
sparing sensory nerves was concluded (Table 2). 
 
Then  physiotheray was started and 
subsequently his Sphincter function recovered. He 
showed improvement of upper extremity with 
which he started feeding himself but there was no 
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Table 2. Nerve conduction study  
. 
 Normal value Patient value 
Motor nerve conduction    
NCV(m/S)    
Tibial(R)  >48    NR  
Tibial(L)  >48    NR  
Peroneal ( R)  >44    NR  
Peroneal(L)  >44   NR  
Median (R)  >52   NR  
Median (L)  >52   NR  
CMAP    
Tibial (R )  >5    NR  
Tibial (L )  >5  NR  
Peroneal ( R)  >2     NR  
Peroneal ( L)  >2    NR  
Median (R  )  >4   0.3  
SENSORY NERVE    CONDUCTION 
SNAP amplitude ( micro Volt) 
  
Sural Nerve (R )  >5   6  
Sural Nerve (L )  >5  26  
Medial plantar( R)  >10  28  
CMAP = Compound muscle action potential, NCV = Nerve conduction velocity; SNAP = Sensory nerve action 
potential; NR =No response. 
 
Figure3: The patient with Organophosphate poisoning on mechanical ventilator at MICU of TASH 






Organophosphate poisoning is one of the 
commonest types of poisoning in Ethiopia for 
suicidal intent and is one of the commonest causes 
of intensive care unit admissions and mortality (1, 
2, 3, 4). In the case reported here it was severe 
poisoning and majority of complications described 
in literatures were observed in succession in this 
patient (6, 7, 8, 11) although confirmatory tests 
like RBC Cholinesterase level were not 
determined. One of the challenging situations in 
our case was intractably prolonged cholinergic 
features and central nervous system manifestations 
like coma and seizure. These manifestations were 
recurring and the patient was kept on high dose 
Atropine for three weeks. Similarly, Chia-Chang 
described in a case report of a 28 years Taiwanese 
woman a prolonged Cholinergic features for many 
days and needed Atropine up to 80 mg in an hour 
with a total dose of 11,665 mg in 17 days who also 
took Pralidoxime (11). Such delayed 
manifestations are reported to occur because of 
Acetylcholiesterase Enzyme (AChE) aging, poor 
rephosphorylation and decreased synthesis of new 
enzymes (6,10).  
 
Our patient developed respiratory failure at 
the fourth day of poisoning which is typical 
duration for Intermediate Syndrome. Intermediate 
Syndrome occurs between the initial acute 
Cholinergic manifestations and the late 
Organophosphate Induced Delayed Neuropathy 
and was first described by wadia etal (9) but the 
name of the syndrome was given by Karalliedde 
(7). The basis for Intermediate Syndrome (the 
Nicotinic Syndrome) is that Nicotinic transmission 
requires inhibition of at least 80% of the synaptic 
AChE unlike the Muscarinic Synapses and nerve 
endings where AChE can be easily inhibited and 
the Nicotinic Syndrome occurs only in severe 
poisoning. The end result is hyperstimulation of 
the Neuromuscular Junction by excessive 
Acetylcholine, initially resulting in fasciculation, 
which later is followed by Neuromuscular 
Paralysis; the effect of intermediate syndrome may 
last for 2-18 days (7,8,9). In Intermediate 
Syndrome characteristically muscles of the neck, 
proximal limb, and the eyes, bulbar and 
respiratory groups are affected. In our patient 
respiratory muscle groups were affected causing 
respiratory failure but other groups of muscles 
have not been affected. In Organophosphate 
Poisoning respiratory failure is very important 
complication which can lead to significant 
morbidity and mortality. In addition to respiratory 
muscle weakness other contributing causes of 
respiratory failure could be respiratory tract 
infections, air way obstruction by secretions, 
Pulmonary Edema, and Central Respiratory Center 
Depression. 
 
The late feature which occurred in our patient 
was sub acutely developed weakness of lower and 
upper extremity which was diagnosed to be 
Polyneuropathy clinically and in nerve conduction 
study. There has been diagnostic challenge in this 
phase as it was a rare phenomenon; Myelography 
and spine x-rays were ordered which turned out to 
be normal. OPC are known to cause delayed 
neurological complications, notably 
Organophosphates Induced Delayed 
Polyneuropathy (OPIDPN). OPIDPN is typically a 
subacute sensory motor nerve disease occurring 2-
4 weeks after OPC poisoning and affects mainly 
the distal groups of muscles earlier. Spinal cord 
can also be affected in delayed neurologic 
manifestations Organophosphate associated 
Myelopathy (5,11) and this may be the cause of 
fecal and urinary incontinence in our patient 
although MRI was not done. The occurrence of 
OPIDN is said to follow the phosphorylation and 
subsequent ageing of an enzyme in axons called as 
Neuropathy Target Esterase (8). In this case the 
sub acute course of neurological manifestations 
coming after weeks of Organophosphate 
poisoning is classical for OPIDPN. Commonly the 
Clincopathology is sensory motor involvement of 
the peripheral nerves but pure or predominant 
motor axononal involvement similar to our patient 
has also been reported (14).  The management in 
severe Organophosphates poisoning is supportive 
care of Homeostasis, administration of high dose 
of Atropine and rephosphorylation attempts by 
Oximes. Airway control and adequate 
Oxygenation are paramount in Organophosphate 
poisonings and Intubation may be necessary in 
cases of respiratory distress. Immediate aggressive 
use of Atropine may eliminate the need for 
intubation, like up 3-7mg bolus and 1-2 mg every 
3-5min until desired effects are obtained. 
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Adequate Atropinization is demonstrated by 
assessing a combination of signs including pupils, 
pulse rate, pulmonary secretions and mental state. 
It is not desirable to use any one criterion alone, 
because cases are seen where pupils do not dilate 
or pulse does not become fast in spite of adequate 
doses. Once Atropinized, a maintenance type dose 
at 1-3 mg 1/2 hourly is usually sufficient (12). The 
next unclear issue is about Oximes such as P2AM. 
P2AM is generally given in most intensive care 
units at a dose of 1 gm 4 to 6 hourly. Oximes 
displace the Organophosphates from the 
Acetylcholine Esterases and bind to the enzyme 
itself. Although these agents appear useful 
theoretically, in practice their effect is not 
confirmed in human studies to be useful. For 
instance in 1991, De Silva studied the treatment of 
Organophosphate poisoning with Atropine and 2-
PAM and, later the same year, with Atropine 
alone. He found that Atropine seemed to be as 
effective as Atropine plus 2-PAM in the treatment 
of Acute Organophosphate Poisoning 
(13).Management of intermediate syndrome and 
OPIDPN is by early detection and supportive care 
like the case of respiratory failure   management. 
There is no specific therapy for the late-onset 
Polyneuropathy due to Organophosphate 
compounds. 
 
In conclusion, patients with severe 
Organophosphate Poisoning can have delayed 
Cholinergic manifestations which would need 
large dosage of Atropine administration and 
thorough evaluation of clinical features is needed 
to titrate the dose down and discontinue it. 
Moreover, careful follow-up is needed for the rare 
complications of Organophosphate Poisoning like 
Intermediate Syndrome and OPIDIN. Therefore, I 
recommend health care workers should be aware 
of these complications, their manifestations and 
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